CD44 and breast carcinoma: To confirm the stemness and immunomodulation markers expression on mouse breast cancer cell lines, we analyzed the expression of CD44 and CD274 (PD-L1) with flow cytometry in two cell lines, EO771 and 4T1 (Supplementary Figure 4).